KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Invested Capital (2019 - 2025)

Vir Biotechnology (VIR) has disclosed Return on Invested Capital for 7 consecutive years, with 0.61% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital fell 13.0% to 0.61% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.61% through Dec 2025, down 13.0% year-over-year, with the annual reading at 0.5% for FY2025, 7.0% down from the prior year.
  • Return on Invested Capital hit 0.61% in Q4 2025 for Vir Biotechnology, up from 0.63% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.69% in Q1 2022 to a low of 0.63% in Q3 2025.
  • Historically, Return on Invested Capital has averaged 0.2% across 5 years, with a median of 0.38% in 2024.
  • Biggest five-year swings in Return on Invested Capital: surged 124bps in 2022 and later tumbled -96bps in 2023.
  • Year by year, Return on Invested Capital stood at 0.34% in 2021, then dropped by -21bps to 0.27% in 2022, then tumbled by -252bps to 0.41% in 2023, then fell by -19bps to 0.49% in 2024, then dropped by -26bps to 0.61% in 2025.
  • Business Quant data shows Return on Invested Capital for VIR at 0.61% in Q4 2025, 0.63% in Q3 2025, and 0.6% in Q2 2025.